Forbion
Boston, Massachusetts
Firm Location:Boston, Massachusetts • Munich, Germany • Amsterdam, Netherlands • Netherlands • Denmark • Cambridge, United Kingdom • Naarden, Netherlands
Investor Firms That Co-Invest with Forbion
General AtlanticRA CapitalCambridge Innovation CapitalF-Prime Capital PartnersHigh-Tech GründerfondsDomain AssociatesNovartis Venture FundAtlas VentureARCH Venture PartnersAlta PartnersThird Rock VenturesRiverVestBayern KapitalYsios CapitalFounders FundPfizer Venture InvestmentsArcus VenturesNew Enterprise Associates (NEA)RTW InvestmentsKurma PartnersNextech InvestLongwood FundSanofi VenturesSeventure PartnersPontifax Venture CapitalSofinnova InvestmentsAndera PartnersAccess Biotechnology4See VenturesBrandon Capital PartnersBGV (BioGeneration Ventures)AmorchemAscendant BioCapitalAglaia BioMedical VenturesINKEF CapitalSoffinova PartnersPivotal bioVenture PartnersRed Tree Venture CapitalVersant VenturesPolaris Partners5am VenturesOrbiMedSeroba Life SciencesEQT Life Sciences
Forbion Team
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Investors in Naarden (Netherlands), Investors in Amsterdam (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
Investors in Amsterdam (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Netherlands
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Munich (Germany)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Amsterdam (Netherlands)
Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Denmark
Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B)
Investors in Naarden (Netherlands)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Munich (Germany)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed)
Investors in Cambridge (United Kingdom)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
Investors in Netherlands
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)
Investors in Amsterdam (Netherlands)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A)